top of page

Centre for Oncology and Immunology Makes a Strong Presence at the First Asia Pacific Symposium on Acute Myeloid Leukaemia

The Centre for Oncology and Immunology (COI) is proud to have participated in the First Asia Pacific Symposium on Acute Myeloid Leukaemia (AML), which took place from April 10-13, 2024 at the University of Hong Kong. This groundbreaking event brought together leading experts in the field of AML to discuss the latest advances in biology, translational research, clinical trials and innovative treatment practices.

Professor Anskar Leung, a principal investigator at COI, played a pivotal role in the event as a co-organizer, speaker and moderator. Professor Leung’s expertise in AML and his extensive research background helped shape the course of the symposium, ensuring that it addressed the most pressing issues and provided a platform for the exchange of cutting-edge ideas and knowledge. With a particular emphasis on the insights from the Asia Pacific regions, the event offered a unique perspective, addressing the regions’ variations in disease profiles, research progress and healthcare systems compared to Western counterparts.

In addition to Professor Leung’s instrumental role, COI was also represented by one of our esteemed overseas principal investigators, Dr. Steven Chan. As a leading expert in the field, Dr. Chan was invited to share his insights and latest research findings as a speaker at the event. His contribution further solidified COI’s position as a key player in advancing the understanding of treatment for AML.

COI’s presence at the symposium extended beyond the contributions of Professor Leung and Dr. Chan, as numerous COI researchers also attended the event. Their participation in ‘Meet the Expert’ lunches and poster sessions at the event allowed them to gain valuable knowledge on the latest developments in AML research and treatment, which will undoubtedly enhance the Centre’s ongoing efforts in the field. Dr. Nelson Ng, a postdoctoral fellow from Professor Leung’s team and also a speaker at the event, shared his insights, “The symposium not only showcased the latest developments in AML research but also emphasised the importance of collaboration between researchers and clinicians. I left the event feeling motivated and equipped with new ideas to apply to my own research, ultimately aiming to improve patient outcomes."

The Centre for Oncology and Immunology’s significant involvement in the First Asia Pacific Symposium on Acute Myeloid Leukaemia highlights its dedication to advancing AML understanding and treatment. This further reinforces its position as a leader in the field, demonstrating its commitment to addressing unmet needs in the immuno-oncology space.

Stay updated on COI’s latest news and research breakthroughs by following us on our social media platforms and visiting our website. Together, we can make a difference in the lives of those affected by cancer.


bottom of page